treatment of chronic delta hepatitis: a nine-year retrospective analysis

Treatment of Chronic Delta Hepatitis: A Nine-Year Retrospective Analysis

BACKGROUND Chronic delta hepatitis is the most severe form of viral hepatitis, for which interferon administration is the only available treatment. However, the efficacy of interferon treatment is affected by the dose and duration of treatment, and relapse rates are high. OBJECTIVES In this study, we sought to evaluate the efficacy of treatment with pegylated interferon and observe the relaps...

treatment of chronic delta hepatitis

Treatment of Chronic Delta Hepatitis

Please cite this paper as: Rizzetto, M. Treatment of Chronic Delta Hepatitis. Hepat Mon. 2011;11(9):701-2. DOI: 10.5812/kowsar.1735143X.759 Implication for health policy/practice/research/medical education: Delta Hepatitis treatment is a controversial issue. There are a few randomized, double blind, controlled studies on HDV treatment. Up to now, α-INF is the only confirmed medicine by FDA to h...

Tuberculosis in dialysis patients: a nine-year retrospective analysis.

INTRODUCTION Diagnosis of tuberculosis (TB) among dialysis patients may be difficult because of increased frequency of extra-pulmonary presentations, atypical clinical manifestations, and non-specific symptoms. This study aimed to investigate the spectrum of clinical presentations and outcome in dialysis patients during a nine-year period. METHODOLOGY A total of 651 patients undergoing hemodi...

Treatment of Chronic Hepatitis B with Tenofovir

Background:Tenofovir is among the first-line treatments for chronic hepatitis B (CHB) virus infection. We evaluated the efficacy of Tenofovir in the treatment of Iranian adult patients with CHB. Methods: In a retrospective study, we evaluated 154 HBsAg positive patients referred to Sadoughi hospital in Yazd-Iran for treatment ...

Treatment of chronic hepatitis delta with pegylated interferon-α2b

Background/Aims: Chronic hepatitis D is difficult to treat. The present pilot study investigated the efficacy and tolerability of pegylated (PEG)-interferon (IFN)-a2b in chronic hepatitis D. Patients and Methods: Twelve patients with chronic hepatitis D were prospectively treated with 1.5 mg/kg PEG-IFN-a2b for 48 weeks and followed for 24 weeks. Sustained response (SR) was defined as undetectab...